Prevention on MSN
Scientists Say This Weight-Loss Drug Is Like ‘Exercise in a Pill’—But What Do Doctors Think?
An experimental new medication claims to help people lose weight without muscle loss. Here’s what you need to know about the ...
Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Knee Osteoarthritis Clinical ...
Clinical trial achieved all three primary objectives with no significant safety issues being reported. Results indicate that Emrosi can be safely used for up to 16 weeks with no d ...
MDNA11 demonstrates durable anti-tumor activity in phase-2 eligible expansion cohorts, enriched for immune checkpoint resistant melanoma, MSS endometrial cancer, MSI-H and TMB-H cancers, in each case ...
Company addresses FDA requests regarding formulation excipient – Global site start-up activities continue, with first-patient-in for ...
Given the recent interest in longevity, antiaging supplements are rising in popularity, and among them, NAD+ is at the ...
Democratic Rep. Haley Stevens, who is running for an open Senate seat in Michigan, formally introduced an article of ...
The move by Representative Haley Stevens, a Michigan Democrat who is running for Senate, does not have the support of her ...
Executives on a DealBook Summit task force panel said fear was not the way to build teams capable of navigating difficult times.
Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, announced the publication ...
ROME, Italy, Dec. 10, 2025 /PRNewswire/ -- Fondazione Telethon announced today that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for Waskyra, an ex ...
A recently approved antibody drug from Regeneron Pharmaceuticals eradicates residual traces of multiple myeloma after initial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback